Interestingly, the elevated expression of YTHDF2 was positively correlated with the OS and RFS of lung cancer patients, which was attributed to YTHDF2 promoting the enrichment of tumor-infiltrating lymphocytes and inhibiting the expression of PD-L1 [60, 61]. Here, YTHDF2 is linked to lung carcinoma.